Engineered Veterinary Vectored Immunotherapy and Vaccines: EVVIVAX

Contact image
Engineered Veterinary Vectored Immunotherapy and Vaccines
Address:
Via Castel Romano, 100

Rome
00128
Italy
Fax:
V.A.T. IT 13919361009
Send an Email
(optional)
Miscellaneous Information:

Engineered Veterinary Vectored Immunotherapy and Vaccines: EVVIVAX

EVVIVAX is a spin-off of Takis Biotech, a company developing a number of Innovative Immunotherapies

EVVIVAX is at the forefront of nucleic-acid based therapies, process development, industrial scale production and clinical trial execution

EVVIVAX stems from new, European platform technologies, aims to offer novel therapeutic avenues to pet cancer patients, with the strong translational potential to complement current human Immune-Oncology approaches in the next future.

Evvivax News

  • 10-12 Apr 2017

    10-12 Apr 2017 - EVVIVAX at the World Veterinary Vaccine Conference, Washington DC, USA Join us at t...
  • 7 Apr 2017

    7 Apr 2017: EVVIVAX Visiting PennVet, Philadelphia, USA Dr Luigi Aurisicchio, CEO at EVVIVAX and Pre...
  • 10-12 Oct 2016

    Barcelona, 10-12 October 2016: EVVIVAX will be at the World Veterinary Vaccine Meeting
  • 6 Sep 2016

    London, 6 September 2016:EVVIVAX has participated at the meeting "Comparative Oncology: The Next Fro...